alscarmuzza
Established Member
- Reaction score
- 127
<dl id="citationFields" class="citation-fields" data-auto="citation_fields"><dt data-auto="citation_field_label">Authors:
</dt><dd data-auto="citation_field_value">Sasaki M; Department of Geriatrics and Vascular Medicine, Tokyo Medical and Dental University Graduate School of Medicine, Tokyo, Japan.
Shinozaki S; Department of Geriatrics and Vascular Medicine, Tokyo Medical and Dental University Graduate School of Medicine, Tokyo, Japan; Department of Arteriosclerosis and Vascular Biology, Tokyo Medical and Dental University Graduate School of Medicine, Tokyo, Japan. Electronic address: sinozaki.vasc@tmd.ac.jp.
Shimokado K; Department of Geriatrics and Vascular Medicine, Tokyo Medical and Dental University Graduate School of Medicine, Tokyo, Japan.</dd><dt data-auto="citation_field_label">Source:</dt><dd data-auto="citation_field_value">Biochemical And Biophysical Research Communications [Biochem Biophys Res Commun] 2016 Feb 25. <cite>Date of Electronic Publication: </cite>2016 Feb 25.</dd><dt data-auto="citation_field_label">Publication Type:</dt><dd data-auto="citation_field_value">JOURNAL ARTICLE</dd><dt data-auto="citation_field_label">Language:</dt><dd data-auto="citation_field_value">English</dd><dt data-auto="citation_field_label">Journal Info:</dt><dd data-auto="citation_field_value"><cite>Publisher: </cite>Academic Press <cite>NLM ID: </cite>0372516 <cite>Publication Model: </cite>Print-Electronic <cite>Cited Medium: </cite>Internet <cite>ISSN: </cite>1090-2104 (Electronic) <cite>Linking ISSN: </cite>0006291X <cite>NLM ISO Abbreviation: </cite>Biochem. Biophys. Res. Commun. </dd><dt data-auto="citation_field_label">Imprint Name(s):</dt><dd data-auto="citation_field_value"><cite>Publication</cite>: <2002->: San Diego, CA : Academic Press
<cite>Original Publication</cite>: New York, Academic Press.</dd><dt data-auto="citation_field_label">Abstract:</dt><dd data-auto="citation_field_value">Dihydrotestosterone (DHT) causes the regression of human hair follicles in the parietal scalp, leading to androgenic alopecia (Androgenetic Alopecia). Sulforaphane (SFN) increases the expression of DHT degrading enzymes, such as 3α-hydroxysteroid dehydrogenases (3α-HSDs), and, therefore, SFN treatment may improve Androgenetic Alopecia. To determine the effects of SFN on hair growth, we administered SFN (10 mg/kg BW, IP) or vehicle (DMSO) to ob/ob mice for six weeks and examined hair regeneration and the plasma levels of testosterone and DHT. We also tested the effects of SFN on the expression of two forms of 3α-HSD, aldo-keto reductase 1c21 and dehydrogenase/reductase (SDR family) member 9, both in vitro and in vivo. SNF significantly enhanced hair regeneration in ob/ob mice. The mice treated with SFN showed lower plasma levels of testosterone and DHT than those treated with vehicle. SFN increased the mRNA and protein levels of the two forms of 3α-HSD in the liver of the mice and in cultured murine hepatocyte Hepa1c1c7 cells. These results suggest that SFN treatment increases the amount of 3α-HSDs in the liver, accelerates the degradation of blood DHT, and subsequently blocks the suppression of hair growth by DHT.
(Copyright © 2016. Published by Elsevier Inc.)</dd><dt data-auto="citation_field_label">Contributed Indexing:</dt><dd data-auto="citation_field_value"><cite>Keywords: </cite>3α-HSD; Androgenetic alopecia; dihydrotestosterone; metabolic syndrome; sulforaphane</dd><dt data-auto="citation_field_label">Entry Date(s):</dt><dd data-auto="citation_field_value"><cite>Date Created: </cite>20160229 <cite>Latest Revision: </cite>20160301
Did a quick Google search and found that there are some Sulforaphane topicals out there.
</dd></dl>
</dt><dd data-auto="citation_field_value">Sasaki M; Department of Geriatrics and Vascular Medicine, Tokyo Medical and Dental University Graduate School of Medicine, Tokyo, Japan.
Shinozaki S; Department of Geriatrics and Vascular Medicine, Tokyo Medical and Dental University Graduate School of Medicine, Tokyo, Japan; Department of Arteriosclerosis and Vascular Biology, Tokyo Medical and Dental University Graduate School of Medicine, Tokyo, Japan. Electronic address: sinozaki.vasc@tmd.ac.jp.
Shimokado K; Department of Geriatrics and Vascular Medicine, Tokyo Medical and Dental University Graduate School of Medicine, Tokyo, Japan.</dd><dt data-auto="citation_field_label">Source:</dt><dd data-auto="citation_field_value">Biochemical And Biophysical Research Communications [Biochem Biophys Res Commun] 2016 Feb 25. <cite>Date of Electronic Publication: </cite>2016 Feb 25.</dd><dt data-auto="citation_field_label">Publication Type:</dt><dd data-auto="citation_field_value">JOURNAL ARTICLE</dd><dt data-auto="citation_field_label">Language:</dt><dd data-auto="citation_field_value">English</dd><dt data-auto="citation_field_label">Journal Info:</dt><dd data-auto="citation_field_value"><cite>Publisher: </cite>Academic Press <cite>NLM ID: </cite>0372516 <cite>Publication Model: </cite>Print-Electronic <cite>Cited Medium: </cite>Internet <cite>ISSN: </cite>1090-2104 (Electronic) <cite>Linking ISSN: </cite>0006291X <cite>NLM ISO Abbreviation: </cite>Biochem. Biophys. Res. Commun. </dd><dt data-auto="citation_field_label">Imprint Name(s):</dt><dd data-auto="citation_field_value"><cite>Publication</cite>: <2002->: San Diego, CA : Academic Press
<cite>Original Publication</cite>: New York, Academic Press.</dd><dt data-auto="citation_field_label">Abstract:</dt><dd data-auto="citation_field_value">Dihydrotestosterone (DHT) causes the regression of human hair follicles in the parietal scalp, leading to androgenic alopecia (Androgenetic Alopecia). Sulforaphane (SFN) increases the expression of DHT degrading enzymes, such as 3α-hydroxysteroid dehydrogenases (3α-HSDs), and, therefore, SFN treatment may improve Androgenetic Alopecia. To determine the effects of SFN on hair growth, we administered SFN (10 mg/kg BW, IP) or vehicle (DMSO) to ob/ob mice for six weeks and examined hair regeneration and the plasma levels of testosterone and DHT. We also tested the effects of SFN on the expression of two forms of 3α-HSD, aldo-keto reductase 1c21 and dehydrogenase/reductase (SDR family) member 9, both in vitro and in vivo. SNF significantly enhanced hair regeneration in ob/ob mice. The mice treated with SFN showed lower plasma levels of testosterone and DHT than those treated with vehicle. SFN increased the mRNA and protein levels of the two forms of 3α-HSD in the liver of the mice and in cultured murine hepatocyte Hepa1c1c7 cells. These results suggest that SFN treatment increases the amount of 3α-HSDs in the liver, accelerates the degradation of blood DHT, and subsequently blocks the suppression of hair growth by DHT.
(Copyright © 2016. Published by Elsevier Inc.)</dd><dt data-auto="citation_field_label">Contributed Indexing:</dt><dd data-auto="citation_field_value"><cite>Keywords: </cite>3α-HSD; Androgenetic alopecia; dihydrotestosterone; metabolic syndrome; sulforaphane</dd><dt data-auto="citation_field_label">Entry Date(s):</dt><dd data-auto="citation_field_value"><cite>Date Created: </cite>20160229 <cite>Latest Revision: </cite>20160301
Did a quick Google search and found that there are some Sulforaphane topicals out there.
</dd></dl>